Yingtong Chen

49 Huayuan North Road
Haidian, 100191, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

CD73 inhibitor enhances the antitumor activity of selinexor in multiple myeloma by restoring the activation of CD8+ T cells.

CD73 inhibitor enhances the antitumor activity of selinexor in multiple myeloma by restoring the activation of CD8+ T cells.

Journal: Cancer gene therapy

Published: February 06, 2026

Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patients.

Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patients.

Journal: Annals of hematology

Published: February 03, 2026

Current progress of CDC20 in cancer development and targeting CDC20 for cancer therapy.

Current progress of CDC20 in cancer development and targeting CDC20 for cancer therapy.

Journal: Carcinogenesis

Published: October 26, 2025

Inhibition of CDC20 suppresses the development and progression of mantle cell lymphoma through PI3K/AKT pathway.

Inhibition of CDC20 suppresses the development and progression of mantle cell lymphoma through PI3K/AKT pathway.

Journal: Annals of hematology

Published: July 13, 2025

Clinical outcomes and therapeutic modalities in older Chinese patients with MCL: a multi-center real-world retrospective study.

Clinical outcomes and therapeutic modalities in older Chinese patients with MCL: a multi-center real-world retrospective study.

Journal: Annals of medicine

Published: March 28, 2025

TP53 mutation heterogeneity reveals distinct prognoses in mantle cell lymphoma.

TP53 mutation heterogeneity reveals distinct prognoses in mantle cell lymphoma.

Journal: Annals of hematology

Published: September 11, 2024

Multi-omics and single cell characterization of cancer immunosenescence landscape.

Multi-omics and single cell characterization of cancer immunosenescence landscape.

Journal: Scientific data

Published: December 18, 2023

1q21+ is associated with poor prognosis in newly diagnosed multiple myeloma patients with extramedullary disease: a retrospective study.

1q21+ is associated with poor prognosis in newly diagnosed multiple myeloma patients with extramedullary disease: a retrospective study.

Journal: Annals of hematology

Published: May 01, 2023

Moxifloxacin as a contrast agent of two-photon microscopic imaging for detecting colorectal diseases.

Moxifloxacin as a contrast agent of two-photon microscopic imaging for detecting colorectal diseases.

Journal: Journal of biophotonics

Published: November 25, 2022

Dual Negativity of CD56 and CD117 Links to Unfavorable Cytogenetic Abnormalities and Predicts Poor Prognosis in Multiple Myeloma.

Dual Negativity of CD56 and CD117 Links to Unfavorable Cytogenetic Abnormalities and Predicts Poor Prognosis in Multiple Myeloma.

Journal: Journal of clinical medicine

Published: September 19, 2022

p53 directly downregulates the expression of CDC20 to exert anti-tumor activity in mantle cell lymphoma.

p53 directly downregulates the expression of CDC20 to exert anti-tumor activity in mantle cell lymphoma.

Journal: Experimental hematology & oncology

Published: June 01, 2022

Clinical characteristics and survival outcomes of newly diagnosed multiple myeloma patients presenting with extramedullary disease: A retrospective study.

Clinical characteristics and survival outcomes of newly diagnosed multiple myeloma patients presenting with extramedullary disease: A retrospective study.

Journal: Leukemia research

Published: November 30, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026